ReShape Lifesciences Investor Relations Material
Latest events
Q4 2024
ReShape Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ReShape Lifesciences Inc
Access all reports
ReShape Lifesciences Inc. is a medical device company specializing in weight-loss solutions and metabolic health treatments. The company’s product portfolio includes minimally invasive devices designed to assist in weight management, such as intragastric balloon systems and laparoscopic medical implants. ReShape also provides support programs and digital tools to aid patients and healthcare providers in managing obesity and related health conditions. The company is headquartered in San Clemente, California, and its shares are listed on the NASDAQ Stock Exchange.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
RSLS
Country
🇺🇸 United States